stockrow
Friday 6 November 2026
Export COCH’s income statement to Excel — free account
Envoy Medical, Inc.
COCH Healthcare Medical Devices
Envoy Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $241,000.00, up 7.11% from fiscal 2024.
- Revenue
- +57.1%
- EPS
- −42.9%
- Free cash flow
- −22.4%
Quarter to September 2026, against a year earlier
7.19
0.09
+1.27%
Follow COCH
Alert me
Envoy Medical, Inc. (COCH) P/E ratio
Envoy Medical, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 11.3× (December 2022) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 13 more quarters | Free account |
Against its own ten years
Low 0.0×
High 11.3×
Ten-year median
0.0×
Current reading's percentile
84
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MDAI Spectral AI, Inc. compare | n/m |
| CVRX CVRx, Inc. compare | n/m |
| ECOR electroCore, Inc. compare | n/m |
| SRTS Sensus Healthcare, Inc. compare | n/m |
| MYO Myomo, Inc. compare | n/m |
| COCH Envoy Medical, Inc. | n/m |
| XTNT Xtant Medical Holdings, Inc. compare | n/m |
| SNWV Sanuwave Health Inc. compare | 1.3× |
| LNSR LENSAR, Inc. compare | 3.9× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)